Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person UniProt:Q9UKC9 FBXL2
| Class:Id | ReferenceGeneProduct:90467 |
|---|---|
| _chainChangeLog | chain:1-423 added on Fri February 6 2015 |
| _displayName | UniProt:Q9UKC9 FBXL2 |
| _timestamp | 2026-02-20 22:09:40 |
| chain | chain:1-423 |
| checksum | 61938E434618BA3D |
| comment | FUNCTION Calcium-activated substrate recognition component of the SCF (SKP1-cullin-F-box protein) E3 ubiquitin-protein ligase complex, SCF(FBXL2), which mediates the ubiquitination and subsequent proteasomal degradation of target proteins (PubMed:22020328, PubMed:22323446, PubMed:31209342). Unlike many F-box proteins, FBXL2 does not seem to target phosphodegron within its substrates but rather calmodulin-binding motifs and is thereby antagonized by calmodulin (PubMed:22020328, PubMed:22323446). This is the case for the cyclins CCND2 and CCND3 which polyubiquitination and subsequent degradation are inhibited by calmodulin (PubMed:22020328, PubMed:22323446). Through CCND2 and CCND3 degradation induces cell-cycle arrest in G(0) (PubMed:22020328, PubMed:22323446). SCF(FBXL2) also mediates PIK3R2 ubiquitination and proteasomal degradation thereby regulating phosphatidylinositol 3-kinase signaling and autophagy (PubMed:23604317). PCYT1A monoubiquitination by SCF(FBXL2) and subsequent degradation regulates synthesis of phosphatidylcholine, which is utilized for formation of membranes and of pulmonary surfactant (By similarity). The SCF(FBXL2) complex acts as a regulator of inflammation by mediating ubiquitination and degradation of TRAF proteins (TRAF1, TRAF2, TRAF3, TRAF4, TRAF5 and TRAF6) (By similarity). The SCF(FBXL2) complex acts as a negative regulator of the NLRP3 inflammasome by mediating ubiquitination and degradation of NLRP3 (PubMed:26037928). The GGTase-3 complex, composed of PTAR1 and RABGGTB, geranylgeranylates and targets FBXL2 to the cellular membranes, where FBXL2 forms part of the SCF(FBXL2) complex that mediates the degradation of membrane-anchored proteins (PubMed:31209342, PubMed:32128853).PATHWAY Protein modification; protein ubiquitination.SUBUNIT Part of the SCF (SKP1-CUL1-F-box) E3 ubiquitin-protein ligase complex SCF(FBXL2) composed of CUL1, SKP1, RBX1 and FBXL2 (PubMed:10531037, PubMed:31209342, PubMed:32128853). Interacts with calmodulin; may antagonize substrate ubiquitination by SCF(FBXL2) (PubMed:22020328). May interact with PIK3R1 (PubMed:23604317). Interacts with PTPN13 (PubMed:23604317).SUBUNIT (Microbial infection) Interacts with hepatitis C virus non-structural protein 5A (NS5A) and less efficiently, with hepatitis C virus non-structural protein 5B (NS5B); a reaction crucial for hepatitis C virus RNA replication.INTERACTION Expressed in brain, heart, kidney, liver, lung, pancreas and placenta.DOMAIN The CAAX motif is a signal for the geranylgeranylation of FBXL2 and is required for its association with cell membranes and the recruitment of substrates to the active SCF(FBXL2) complex.PTM Phosphorylated by GSK-beta (GSK3B), promoting recognition by FBXO3, leading to its ubiquitination by the SCF(FBXO3) complex.PTM Ubiquitinated at Lys-201 by the SCF(FBXO3) complex in response to lipopolysaccharide (LPS), leading to its degradation by the proteasome.PTM Geranylgeranylation at Cys-420 is mediated by the GGTase-3 complex and is required for its association with cell membranes and the recruitment of substrates to the active SCF(FBXL2) complex.MISCELLANEOUS Deletion of the F-box domain creates a dominant-negative protein that inhibits replication of hepatitis C virus RNA when overexpressed in a hepatoma cell line; this inhibition could be overcome by NS5A coexpression.SEQUENCE CAUTION Extended N-terminus. |
| description | recommendedName: fullName evidence="16"F-box/LRR-repeat protein 2 alternativeName: fullName evidence="14"F-box and leucine-rich repeat protein 2 alternativeName: fullName evidence="12"F-box protein FBL2/FBL3 |
| geneName | FBXL2 FBL2 FBL3 |
| identifier | Q9UKC9 |
| isSequenceChanged | FALSE |
| keyword | 3D-structure Alternative splicing Calcium Calmodulin-binding Host-virus interaction Isopeptide bond Leucine-rich repeat Lipoprotein Membrane Phosphoprotein Prenylation Proteomics identification Reference proteome Repeat Ubl conjugation Ubl conjugation pathway |
| modified | [InstanceEdit:9836292] Weiser, Joel, 2023-05-25 [InstanceEdit:9852000] Weiser, Joel, 2023-11-03 [InstanceEdit:9926675] Weiser, Joel, 2024-11-03 [InstanceEdit:9983091] Weiser, Joel, 2026-02-20 |
| name | FBXL2 |
| referenceDatabase | [ReferenceDatabase:2] UniProt |
| referenceGene | [ReferenceDNASequence:8995974] ENSEMBL:ENSG00000153558 FBXL2 [Homo sapiens] |
| secondaryIdentifier | FBXL2_HUMAN B4DQV0 E9PD06 Q6IAN3 Q9NVQ8 Q9UK27 Q9UKA5 Q9Y3Y9 |
| sequenceLength | 423 |
| species | [Species:48887] Homo sapiens |
| (isoformParent) | [ReferenceIsoform:8972395] UniProt:Q9UKC9-1 FBXL2 [Homo sapiens] [ReferenceIsoform:8972396] UniProt:Q9UKC9-2 FBXL2 [Homo sapiens] |
| (referenceEntity) | [EntityWithAccessionedSequence:8862605] FBXL2 [endoplasmic reticulum membrane] [Homo sapiens] [EntityWithAccessionedSequence:9748664] FBXL2 [cytosol] [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by UniProt:Q9UKC9 FBXL2 (90467)
